Merit Medical Systems - MMSI Stock Forecast, Price & News

5 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Merit Medical Systems in the last year. There are currently 1 hold rating and 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" MMSI shares.
View MMSI analyst ratings or view top-rated stocks.

5 brokerages have issued 1 year target prices for Merit Medical Systems' shares. Their MMSI share price forecasts range from $72.00 to $78.00. On average, they anticipate the company's stock price to reach $73.50 in the next year. This suggests a possible upside of 2.6% from the stock's current price.
View analysts price targets for MMSI or view top-rated stocks among Wall Street analysts.

Merit Medical Systems' stock was trading at $70.62 at the beginning of the year. Since then, MMSI shares have increased by 1.4% and is now trading at $71.61.
View the best growth stocks for 2023 here.

The company is scheduled to release its next quarterly earnings announcement on Wednesday, February 22nd 2023.
View our MMSI earnings forecast.

Merit Medical Systems will be holding an earnings conference call on Wednesday, February 22nd at 5:00 PM Eastern. Interested parties can register for or listen to the call using this link.

Merit Medical Systems, Inc. (NASDAQ:MMSI) posted its quarterly earnings results on Thursday, October, 28th. The medical instruments supplier reported $0.52 earnings per share for the quarter, beating the consensus estimate of $0.44 by $0.08. The medical instruments supplier earned $267.02 million during the quarter, compared to analysts' expectations of $260.61 million. Merit Medical Systems had a net margin of 5.43% and a trailing twelve-month return on equity of 14.14%. The firm's quarterly revenue was up 9.4% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.42 EPS.

158 employees have rated Merit Medical Systems Chief Executive Officer Fred P. Lampropoulos on Glassdoor.com. Fred P. Lampropoulos has an approval rating of 73% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other Merit Medical Systems investors own include Citigroup (C), OraSure Technologies (OSUR), LightPath Technologies (LPTH), Overstock.com (OSTK), EXFO (EXFO), Energy Transfer (ET), RTI Surgical (RTIX), NVIDIA (NVDA), Under Armour (UA) and Advanced Micro Devices (AMD).

Merit Medical Systems trades on the NASDAQ under the ticker symbol "MMSI."

Merit Medical Systems' stock is owned by many different institutional and retail investors. Top institutional shareholders include Conestoga Capital Advisors LLC (3.65%), Emerald Advisers LLC (0.92%), Emerald Mutual Fund Advisers Trust (0.72%), Fisher Asset Management LLC (0.47%), New York State Common Retirement Fund (0.40%) and Fort Washington Investment Advisors Inc. OH (0.39%). Insiders that own company stock include A Scott Anderson, Brian G Lloyd, David Floyd, David Ming-Teh Liu, F Ann Millner, Franklin J Miller, Fred P Lampropoulos, Jill Anderson, Joseph Wright, Lynne Ward, Neil Peterson, Nolan E Karras, Raul Jr Parra and Ronald Frost.
View institutional ownership trends.

Shares of MMSI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of MMSI stock can currently be purchased for approximately $71.61.

Merit Medical Systems (NASDAQ:MMSI) has a market capitalization of $4.08 billion and generates $1.07 billion in revenue each year. The medical instruments supplier earns $48.45 million in net income (profit) each year or $1.08 on an earnings per share basis.

The company employs 6,446 workers across the globe.

Merit Medical Systems' mailing address is 1600 WEST MERIT PARK WAY, SOUTH JORDAN UT, 84095. The official website for the company is www.merit.com. The medical instruments supplier can be reached via phone at (801) 253-1600, via email at awright@merit.com, or via fax at 801-253-1652.